Broxbourne, United Kingdom

Lawrence H Lunts


Average Co-Inventor Count = 3.3

ph-index = 13

Forward Citations = 550(Granted Patents)


Location History:

  • Hertfordshire, GB (1991)
  • Herts, GB (1992 - 1993)
  • Broxbourne, GB (1988 - 1994)

Company Filing History:


Years Active: 1988-1994

Loading Chart...
29 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Lawrence H Lunts in Pharmaceutical Patents

Introduction: Lawrence H Lunts, based in Broxbourne, GB, is a prolific inventor with an impressive portfolio of 29 patents. His contributions to pharmaceutical sciences, particularly in the field of respiratory treatments, have made significant strides in addressing health challenges associated with airway obstructions.

Latest Patents: Among Lunts' latest innovations are his patents concerning Phenethanolamine derivatives. These inventions encompass compounds with unique formulas that possess stimulant properties at beta-2 adrenoreceptors. Such compounds may be utilized in treating diseases related to reversible airways obstruction, including asthma and chronic bronchitis, providing hope for those who suffer from these chronic conditions.

Career Highlights: Lawrence H Lunts has made a notable impact through his role at Glaxo Group Limited. His work is recognized for advancing our understanding and treatment of respiratory ailments, marking him as a key figure in the pharmaceutical industry.

Collaborations: Throughout his career, Lunts has collaborated with esteemed colleagues such as Harry Finch and Alan Naylor. These partnerships have amplified the innovation process, leading to groundbreaking advancements in medication formulations.

Conclusion: Lawrence H Lunts exemplifies innovation within the pharmaceutical sector. His 29 patents, particularly in the development of Phenethanolamine derivatives, highlight his commitment to enhancing medical treatments for respiratory diseases. As he continues to work with talented colleagues at Glaxo Group Limited, his impact in the field of medicine will undoubtedly grow.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…